標(biāo)題: Titlebook: Perspectives in Translational Research in Life Sciences and Biomedicine; Translational Outcom Ena Ray Banerjee Book 2017 Springer Nature Si [打印本頁(yè)] 作者: Holter-monitor 時(shí)間: 2025-3-21 16:57
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine影響因子(影響力)
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine影響因子(影響力)學(xué)科排名
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine網(wǎng)絡(luò)公開度
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine被引頻次
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine被引頻次學(xué)科排名
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine年度引用
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine年度引用學(xué)科排名
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine讀者反饋
書目名稱Perspectives in Translational Research in Life Sciences and Biomedicine讀者反饋學(xué)科排名
作者: Militia 時(shí)間: 2025-3-21 23:47
第144781主題貼--第2樓 (沙發(fā))作者: jumble 時(shí)間: 2025-3-22 01:40
板凳作者: 捕鯨魚叉 時(shí)間: 2025-3-22 05:02
第4樓作者: CEDE 時(shí)間: 2025-3-22 10:44
5樓作者: Hyperlipidemia 時(shí)間: 2025-3-22 13:23
6樓作者: 手銬 時(shí)間: 2025-3-22 17:10
7樓作者: MAL 時(shí)間: 2025-3-22 21:44
8樓作者: PATRI 時(shí)間: 2025-3-23 02:58
9樓作者: Abominate 時(shí)間: 2025-3-23 06:20
10樓作者: 不能根除 時(shí)間: 2025-3-23 12:31
第4樓作者: 最高峰 時(shí)間: 2025-3-23 15:10
第4樓作者: AMEND 時(shí)間: 2025-3-23 18:09
5樓作者: Valves 時(shí)間: 2025-3-23 23:41
5樓作者: conscience 時(shí)間: 2025-3-24 03:14
5樓作者: 連鎖,連串 時(shí)間: 2025-3-24 08:17
5樓作者: cochlea 時(shí)間: 2025-3-24 13:32
6樓作者: 忘恩負(fù)義的人 時(shí)間: 2025-3-24 15:25
6樓作者: obscurity 時(shí)間: 2025-3-24 21:22
6樓作者: Ingest 時(shí)間: 2025-3-25 01:39
6樓作者: semiskilled 時(shí)間: 2025-3-25 06:25
7樓作者: 主動(dòng)脈 時(shí)間: 2025-3-25 11:01
7樓作者: 記成螞蟻 時(shí)間: 2025-3-25 15:07
7樓作者: semble 時(shí)間: 2025-3-25 18:42
7樓作者: Semblance 時(shí)間: 2025-3-25 21:52
8樓作者: Servile 時(shí)間: 2025-3-26 02:59
8樓作者: 索賠 時(shí)間: 2025-3-26 04:29
8樓作者: 細(xì)微的差異 時(shí)間: 2025-3-26 11:49
8樓作者: 占線 時(shí)間: 2025-3-26 13:10
9樓作者: molest 時(shí)間: 2025-3-26 17:18
9樓作者: 從屬 時(shí)間: 2025-3-26 21:45
9樓作者: 深陷 時(shí)間: 2025-3-27 03:11 作者: 清楚 時(shí)間: 2025-3-27 06:07
Validation and Development of an , Riboflavin Pathway Phenotypic Screen Hit as a Small-Molecule Ligand of the Flavin Mononucleotide Riboswitch,an in vitro riboswitch RNA aptamer-binding assay, both of which?are described in detail here along with the riboflavin pathway-specific screen, were developed to further validate the mechanism of action of ribocil and to facilitate the discovery of more potent analogues.作者: 埋伏 時(shí)間: 2025-3-27 13:16
onically recorded and later transcribed for this book. The text includes the edited transcript of the panel discussions and separate presentations by two major industry executives, Richard Ketchum‘ and Robert Mc Sweeney. As with the other volumes in this popular series, this book is not simply inten作者: Gene408 時(shí)間: 2025-3-27 15:20 作者: 輕率看法 時(shí)間: 2025-3-27 18:38
